The American College of Cardiology’s Cardiac Oncology Conference, “Advancing the Cardiovascular Care of the Oncology Patient,” will be held in Washington, D.C., Feb. 9-11, 2024. The event is offered as an interdisciplinary and interspecialty course to provide clinicians and researchers with the tools needed to improve the cardiovascular (CV) health of cancer patients in everyday practice. Image courtesy: Getty Images
February 2, 2024 — The American College of Cardiology’s Cardiac Oncology Conference, “Advancing the Cardiovascular Care of the Oncology Patient,” will be held in person at the Heart House in Washington, D.C., from Feb. 9-11, 2024, with program planners preparing a robust program. The event is offered as an interdisciplinary and interspecialty course to provide clinicians and researchers with the tools needed to improve the cardiovascular (CV) health of cancer patients in everyday practice.
The opening Plenary session, “Perspective from the U.S. Food and Drug Administration (FDA): How to Keep Pace with New Drug Development and Drug Safety” will be presented by Laleh Amiri Kordestani, MD. After two full days covering a wide range of issues and experts, the final day will include a joint session with the American College of Cardiology (ACC) and the American Society of Clinical Oncology (ASCO).
The goal of the multi-day course, notes planners, is to equip the cardio-oncology community with practical scientific knowledge fostering the progression of patient-centered, evidence-based, collaborative cardiovascular and cancer care for patients living with and beyond cancer. According to ACC, the event addresses the educational needs for cardiologists, oncologists, internists, pharmacists, nurses, trainees, and all members of the interprofessional care team who advance the clinical care of, and conduct clinical research that is relevant to, the growing population of cancer patients and survivors at risk for, or suffer from, cardiovascular disease.
Course Chairs are: Ana Barac, MD, PhD, FACC, Inova Health System; and Bonnie Ky, MD, MSCE, FACC, University of Pennsylvania, Perelman School of Medicine. Course Vice Chair is Richard Cheng, MD, MSc, FACC, University of Washington.
An overview of sessions, focus topics and presenters follows.
Friday, February 9
Registration (1:00 - 6:00 p.m.)
Optional Pre-conference Workshop to be held Friday afternoon includes a number of topics:
Pharmacology 101
Pharmacology 101 – Workshop: Alana Ferrari, PharmD, BCOP
How Do I Grow My Career in Cardio-Oncology?
Cardio-Oncology Educational Training: What Do I Need to Learn? How to Structure?: Eric Yang, MD, FACC
Financial and Clinical Considerations in Building a Cardio-Oncology Program: Cathleen Biga, MSN, FACC
How to Build a Career as an Investigator in Cardio-Oncology and Publish Your Work: Bonnie Ky, MD, MSCE, FACC
What I Wish I Knew Before
Moderated Panel Discussion featuring Moderator: Bonnie Ky, MD, MSCE, FACC and panelists: Ana Barac, MD, PhD, FACC; Richard Cheng, MD, FACC; Susan Dent, MD; Teresa López-Fernández, MD; and Eric Yang, MD, FACC
A Networking Reception, hosted by the Cardio-Oncology Section, will be held from 5:30-6:15 p.m.
Saturday, February 10
Registration, Breakfast, and Poster Session (7:00-8:00 a.m.)
Welcome and Plenary Session
“Perspective From the U.S. Food and Drug Administration: How to Keep Pace With New Drug Development and Drug Safety” by Laleh Amiri Kordestani, MD
Panel Discussion - Patient-Focused Drug Development with Moderator: Ana Barac, MD, PhD, FACC, and panelists Julia Maues and Patient Voice from Asma Dilawari, MD
Immunotherapy
Decoding Immunotherapy: Applying Diagnostic Criteria and Navigating the Complexities of Management: Susan Dent, MD; Nicolas Palaskas, MD, FACC
Lung Cancer: Cardiovascular Risks
Spotlight on Lung Cancer: Case Insights Into Radiation, ICI and EGFR Therapies: Nicolas Palaskas, MD, FACC; Lova Sun, MD
Interactive Case-Based Discussion Case Presenters: Nicolas Palaskas, MD, FACC; Lova Sun, MD with Discussants: Daniel Addison, MD; Vivek, Narayan, MD, MS; Nicolas Palaskas, MD, FACC; Lova Sun, MD
GU Malignancies and the Cardiovascular Concerns
GU Malignancies Unveiled: CV Risks in Prostate Cancer and Renal Cell Carcinoma: Vivek, Narayan, MD, MS; Ronald Witteles, MD
Interactive Case-Based Discussion
Case Presenter: Ronald Witteles, MD Discussants: Vivek Narayan, MD, MS; Nicolas Palaskas, MD, FACC; Lova Sun, MD; Alexi Vasbinder, PhD, RN; Ronald Witteles, MD
Adult Survivors of Childhood Cancers
Surviving and Thriving: Promoting CV Health in Adult Survivors of Childhood Cancers: Stephanie Dixon, MD, MPH
Interactive Case-Based Discussion:Stephanie, Dixon, MD, MPH
Pharmacologic and Nonpharmacologic Strategies in the Primordial and Primary
Prevention of Cardiovascular Disease: Stephanie, Dixon, MD, MPH
Cardio Protection via Non-Pharmacologic and Pharmacologic Strategies
Guarding the Heart: Non-Pharmacologic and Pharmacologic Strategies: Richard Cheng, MD, FACC; Lova Sun, MD
How to Risk Stratify in Cancer Patients
Evidence-Based Approaches to Cancer Patient Stratification – Imaging, Biomarkers and More: Bonnie Ky, MD, MSCE, FACC
Interactive Case-Based Discussion with Teresa López-Fernández, MD; Vivek, Narayan, MD, MS; Alexi Vasbinder, PhD, RN
Imaging Cases - Rapid Fire
Imaging Cases – Rapid fire Moderators: Ana Barac, MD, PhD, FACC; Bonnie Ky, MD, MSCE, FACC and Case Presenters: Daniel Addison, MD; Teresa López-Fernández, MD; Eric Yang, MD, FACC
Systems of Care in Interventions in Patients with Advanced Cancer
From Biopsy to Clip: Engaging the Interprofessional Team in Advanced Cancer Interventions: Alana Ferrari, PharmD, BCOP; Eric Yang, MD, FACC
Sunday, February 11
Registration and Breakfast (7:00-7:45 a.m.)
Welcome Back and Poster Awards
Joint Session with the American College of Cardiology (ACC) and the American Society of Clinical Oncology (ASCO)
Breast Cancer and Contemporary Considerations: Susan Dent, MD
Interactive Case-Based Discussion Case Presenter: Susan Dent, MD; Discussants: Ana Barac, MD, PhD, FACC; Teresa López-Fernández, MD
Cardiovascular Needs of Patients Undergoing Stem Cell Transplant: Before, During and After
CV Vigilance in Stem Cell Transplantation: From Pre-Transplant Risk Assessment to Survivorship: Alexi Vasbinder, PhD, RN
Hematological Malignancies: Focus on Chronic Lymphocytic Leukemia
Harmony in Hematology: Cardiovascular Risk Mitigation and Monitoring in CLL Cases: Daniel Addison, MD; Danielle Shafer, DO
Interactive Case-Based Discussion Case Presenters: Daniel Addison, MD; Danielle Shafer, DO with Discussants: Alana Ferrari, PharmD, BCOP ; Teresa López-Fernández, MD; Nicolas Palaskas, MD, FACC
All About Amyloidosis: Ronald Witteles, MD
The event will also include exhibits and an industry sponsored reception offering the chance for face-to-face networking with all attendees during dedicated times in the program.
Registration for Advancing the Cardiovascular Care of the Oncology Patient includes access to the live stream and On Demand access to sessions through Feb. 19, 2024.
More information: www.acc.org